ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CPIX vs RNTX // DIVIDEND YIELD & FCF PAYOUT SAFETY

Cumberland Pharmaceuticals Inc. (NASDAQ) VS. Rein Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: CPIX 3 — RNTX 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CPIX VS. RNTX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CPIX RNTX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 85.00% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -16.40% -35.00% +18.60 CPIX /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield 7.42% — — TIE /fcf-yield <GO>
Operating Margin -6.30% — — TIE /operating-margins <GO>
Net Profit Margin -6.40% — — TIE /net-margins <GO>
Revenue Growth (YoY) 17.60% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety ACTIVE 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.72 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 7/9 2/9 +5.00 CPIX /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 35.3 47.4 -12.10 RNTX /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $65.2M $62.7M $2.5M CPIX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CPIX REV RNTX REV CPIX GROSS % RNTX GROSS % CPIX FCF RNTX FCF
FY 2025 $44.5M $0 85.0% — $4.8M -$19.4M
FY 2024 $37.9M $0 82.6% — -$678.6K -$22.3M
FY 2023 $39.6M $0 — — $6.1M -$19.8M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CPIX // BETA —
RNTX // BETA —